Submitted by Anonymous (not verified) on 20 June 2025 - 14:09
Human medicines European public assessment report (EPAR): Lemtrada, alemtuzumab, Date of authorisation: 12/09/2013, Revision: 26, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Lemtrada, alemtuzumab, Date of authorisation: 12/09/2013, Revision: 26, Status: Authorised